Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Melanoma 44Carcinoma, Non-Small-Cell Lung 16Colorectal Neoplasms 14Lung Neoplasms 11Neoplasm Metastasis 10Pancreatic Neoplasms 9Brain Neoplasms 9Neoplasms 8Triple Negative Breast Neoplasms 6Skin Neoplasms 5Colonic Neoplasms 5Rectal Neoplasms 4Ovarian Neoplasms 4Uveal Melanoma 3Thyroid Neoplasms 3Multiple Myeloma 3Hematologic Neoplasms 3Glioma 3Gastrointestinal Stromal Tumors 3Breast Neoplasms 3Biliary Tract Neoplasms 3Solid Tumor 2Skin Diseases 2Recurrence 2Neurofibromatosis 1 2Lymphoma 2Leukemia, Hairy Cell 2Hereditary Sensory and Autonomic Neuropathies 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2

Interventions

temsirolimus 1binimetinib 1Valproic Acid 1Trabectedin 1Specimen Handling 1Sirolimus 1Laser Therapy 1Immunoglobulin G 1Enoxaparin 1Disulfides 1Cetuximab 1Biopsy 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Soft Tissue Neoplasms × binimetinib × Clear all
NCT02285439 2025-10-07

Study of MEK162 for Children With Low-Grade Gliomas

Children's Hospital Los Angeles

Phase 1/2 Completed
105 enrolled 17 charts
CNS

Brain Neoplasms, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡